Boai NKY Pharmaceuticals Ltd (300109) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.038x

Based on the latest financial reports, Boai NKY Pharmaceuticals Ltd (300109) has a cash flow conversion efficiency ratio of 0.038x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥139.46 Million ≈ $20.41 Million USD) by net assets (CN¥3.69 Billion ≈ $540.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Boai NKY Pharmaceuticals Ltd (300109) total market value for the company's overall valuation and market capitalisation.

Boai NKY Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Boai NKY Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Boai NKY Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Boai NKY Pharmaceuticals Ltd ranked by their cash flow conversion efficiency. Explore Boai NKY Pharmaceuticals Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Guangdong Shenglu Telecommunication Tech Co Ltd
SHE:002446
-0.007x
Kerjaya Prospek Group Bhd
KLSE:7161
0.003x
BJs Restaurants Inc
NASDAQ:BJRI
0.115x
JK Tyre & Industries Limited
NSE:JKTYRE
0.143x
Aegean Airlines S.A.
AT:AEGN
0.357x
Meitav Dash Investments Ltd
TA:MTDS
0.074x
Wangneng Environment Co Ltd
SHE:002034
0.073x
Jiuzhitang Co Ltd
SHE:000989
0.027x

Annual Cash Flow Conversion Efficiency for Boai NKY Pharmaceuticals Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Boai NKY Pharmaceuticals Ltd from 2007 to 2025. View today's stock price for Boai NKY Pharmaceuticals Ltd for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥3.66 Billion
≈ $534.86 Million
CN¥338.11 Million
≈ $49.48 Million
0.093x +30.34%
2024-12-31 CN¥3.61 Billion
≈ $527.92 Million
CN¥256.03 Million
≈ $37.47 Million
0.071x -48.84%
2023-12-31 CN¥3.52 Billion
≈ $515.09 Million
CN¥488.25 Million
≈ $71.45 Million
0.139x +71.74%
2022-12-31 CN¥3.12 Billion
≈ $456.15 Million
CN¥251.77 Million
≈ $36.84 Million
0.081x +532.17%
2021-12-31 CN¥3.40 Billion
≈ $497.55 Million
CN¥43.44 Million
≈ $6.36 Million
0.013x -85.27%
2020-12-31 CN¥3.08 Billion
≈ $450.15 Million
CN¥266.87 Million
≈ $39.05 Million
0.087x +232.53%
2019-12-31 CN¥3.05 Billion
≈ $446.69 Million
CN¥79.64 Million
≈ $11.65 Million
0.026x -31.79%
2018-12-31 CN¥1.28 Billion
≈ $186.75 Million
CN¥48.81 Million
≈ $7.14 Million
0.038x +5.36%
2017-12-31 CN¥1.30 Billion
≈ $190.58 Million
CN¥47.28 Million
≈ $6.92 Million
0.036x -60.99%
2016-12-31 CN¥1.23 Billion
≈ $179.49 Million
CN¥114.14 Million
≈ $16.70 Million
0.093x +68.78%
2015-12-31 CN¥1.16 Billion
≈ $170.16 Million
CN¥64.12 Million
≈ $9.38 Million
0.055x -52.64%
2014-12-31 CN¥400.25 Million
≈ $58.57 Million
CN¥46.60 Million
≈ $6.82 Million
0.116x +89.44%
2013-12-31 CN¥377.06 Million
≈ $55.18 Million
CN¥23.17 Million
≈ $3.39 Million
0.061x +8.28%
2012-12-31 CN¥363.81 Million
≈ $53.24 Million
CN¥20.65 Million
≈ $3.02 Million
0.057x +405.33%
2011-12-31 CN¥350.93 Million
≈ $51.35 Million
CN¥3.94 Million
≈ $576.77K
0.011x -62.77%
2010-12-31 CN¥333.21 Million
≈ $48.76 Million
CN¥10.05 Million
≈ $1.47 Million
0.030x -93.44%
2009-12-31 CN¥62.14 Million
≈ $9.09 Million
CN¥28.57 Million
≈ $4.18 Million
0.460x +593.63%
2008-12-31 CN¥43.93 Million
≈ $6.43 Million
CN¥-4.09 Million
≈ $-598.80K
-0.093x -117.36%
2007-12-31 CN¥17.82 Million
≈ $2.61 Million
CN¥9.56 Million
≈ $1.40 Million
0.536x --

About Boai NKY Pharmaceuticals Ltd

SHE:300109 China Specialty Chemicals
Market Cap
$1.09 Billion
CN¥7.44 Billion CNY
Market Cap Rank
#8568 Global
#2041 in China
Share Price
CN¥12.90
Change (1 day)
+0.23%
52-Week Range
CN¥12.02 - CN¥20.47
All Time High
CN¥149.39
About

Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally. The company produces and sells polyvinyl pyrrolidone (PVP) series products, vinyl methyl ether/maleic anhydride copolymer (PVM/MA, Euroster) copolymer, and oral care products; and medical technology services, such as early tumor screening, molecular diagnostics, and precisio… Read more